In Brief: Abbott Hytrin
Executive Summary
Abbott Hytrin: Federal appeals court rules Jan. 14 that Hytrin parent and divisional patents both expired on Oct. 14, 1995, allowing Novopharm and Geneva terasozin ANDAs to move forward. Since November 1995, the companies have been litigating whether a pre-Uruguay Rounds Agreement Act divisional patent carries the parent patent's application date or its own filing date; the court affirmed the former...